Sanofi\'s Cablivi garners FDA approval for acquired thrombotic thrombocytopenic purpura httpswww.firstwordpharma.comnode1623569Â $SNY

Sanofi's Cablivi garners FDA approval for acquired thrombotic thrombocytopenic purpura https://www.firstwordpharma.com/node/1623569  $SNY

12:46 EST 6 Feb 2019 | FirstWord Pharma

Sanofi's Cablivi garners FDA approval for acquired thrombotic thrombocytopenic purpura https://www.firstwordpharma.com/node/1623569  $SNY

More From BioPortfolio on "Sanofi's Cablivi garners FDA approval for acquired thrombotic thrombocytopenic purpura https://www.firstwordpharma.com/node/1623569  $SNY"